ArticlemBio2025

Low-dose interleukin 2 therapy halts the progression of post-streptococcal autoimmune complications in a rat model of rheumatic heart disease.

Rukshan Ahamed Mohamed Rafeek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.